Patients carrying the FBXL19 rs10782001-GG genotype showed a higher risk of developing paradoxical psoriasis during treatment (OR = 32.85, CI95% = 1.46–738.37, p = 0.0028) [90]. The gene discussed is FBXL19; the disease is psoriasis.